These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 26637279)

  • 61. Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apolipoprotein (a) size polymorphism.
    Kraft HG; Haibach C; Lingenhel A; Brunner C; Trommsdorff M; Kronenberg F; Müller HJ; Utermann G
    Hum Genet; 1995 Mar; 95(3):275-82. PubMed ID: 7868118
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study.
    Brown SA; Morrisett JD; Boerwinkle E; Hutchinson R; Patsch W
    Arterioscler Thromb; 1993 Nov; 13(11):1558-66. PubMed ID: 8218095
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Phenotypic expression of Lp(a) in Spanish children and adolescents].
    Gómez Gerique JA; López Martínez D; Cancelas P; Montoya MT; Gutiérrez MD; Porres A
    Med Clin (Barc); 2000 Jan; 114(1):13-5. PubMed ID: 10782454
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
    Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Discovery of potent small-molecule inhibitors of lipoprotein(a) formation.
    Diaz N; Perez C; Escribano AM; Sanz G; Priego J; Lafuente C; Barberis M; Calle L; Espinosa JF; Priest BT; Zhang HY; Nosie AK; Haas JV; Cannady E; Borel A; Schultze AE; Sauder JM; Hendle J; Weichert K; Nicholls SJ; Michael LF
    Nature; 2024 May; 629(8013):945-950. PubMed ID: 38720069
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).
    Ernst A; Helmhold M; Brunner C; Pethö-Schramm A; Armstrong VW; Müller HJ
    J Biol Chem; 1995 Mar; 270(11):6227-34. PubMed ID: 7890760
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Kringle IV Type 2, Not Low Lipoprotein(a), as a Cause of Diabetes: A Novel Genetic Approach Using SNPs Associated Selectively with Lipoprotein(a) Concentrations or with Kringle IV Type 2 Repeats.
    Tolbus A; Mortensen MB; Nielsen SF; Kamstrup PR; Bojesen SE; Nordestgaard BG
    Clin Chem; 2017 Dec; 63(12):1866-1876. PubMed ID: 28971985
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells.
    Brunner C; Lobentanz EM; Pethö-Schramm A; Ernst A; Kang C; Dieplinger H; Müller HJ; Utermann G
    J Biol Chem; 1996 Dec; 271(50):32403-10. PubMed ID: 8943305
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus.
    DeMeester CA; Bu X; Gray RJ; Lusis AJ; Rotter JI
    Am J Hum Genet; 1995 Jan; 56(1):287-93. PubMed ID: 7825589
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
    Rahman MN; Petrounevitch V; Jia Z; Koschinsky ML
    Protein Eng; 2001 Jun; 14(6):427-38. PubMed ID: 11477223
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans.
    Deo RC; Wilson JG; Xing C; Lawson K; Kao WH; Reich D; Tandon A; Akylbekova E; Patterson N; Mosley TH; Boerwinkle E; Taylor HA
    PLoS One; 2011 Jan; 6(1):e14581. PubMed ID: 21283670
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Apo(a)-kringle IV-type 6: expression in Escherichia coli, purification and in vitro refolding.
    Hrzenjak A; Frank S; Maderegger B; Sterk H; Kostner GM
    Protein Eng; 2000 Sep; 13(9):661-6. PubMed ID: 11054461
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors.
    Ishikawa S; Deguchi T; Hara K; Takuma S; Kayaba K; Tsutsumi A; Kario K; Igarashi M
    J Epidemiol; 1999 Feb; 9(1):32-9. PubMed ID: 10098351
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.
    Hoogeveen RC; Gambhir JK; Gambhir DS; Kimball KT; Ghazzaly K; Gaubatz JW; Vaduganathan M; Rao RS; Koschinsky M; Morrisett JD
    J Lipid Res; 2001 Apr; 42(4):631-8. PubMed ID: 11290835
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Possible association between genetic variability at the apolipoprotein(a) locus and Alzheimer's disease in apolipoprotein E2 carriers.
    Compton D; Wavrant DeVriéze F; Petersen RC; Tangalos E; Li L; Hardy J
    Neurosci Lett; 2002 Oct; 331(1):60-2. PubMed ID: 12359323
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).
    Chitayat S; Kanelis V; Koschinsky ML; Smith SP
    Biochemistry; 2007 Feb; 46(7):1732-42. PubMed ID: 17263558
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups.
    Paré G; Çaku A; McQueen M; Anand SS; Enas E; Clarke R; Boffa MB; Koschinsky M; Wang X; Yusuf S;
    Circulation; 2019 Mar; 139(12):1472-1482. PubMed ID: 30667276
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.
    Gavish D; Azrolan N; Breslow JL
    J Clin Invest; 1989 Dec; 84(6):2021-7. PubMed ID: 2556454
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.
    Jenner JL; Seman LJ; Millar JS; Lamon-Fava S; Welty FK; Dolnikowski GG; Marcovina SM; Lichtenstein AH; Barrett PH; deLuca C; Schaefer EJ
    Metabolism; 2005 Mar; 54(3):361-9. PubMed ID: 15736114
    [TBL] [Abstract][Full Text] [Related]  

  • 80. APO(a) variants and lipoprotein(a) in men with or without myocardial infarction.
    Chimienti G; Lamanuzzi BL; Nardulli M; Colacicco AM; Capurso A; La Gioia R; Scrutinio D; Pepe G
    Exp Mol Pathol; 2002 Aug; 73(1):28-34. PubMed ID: 12127051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.